This is an cohort study to investigate the disease course and treatment response of patients with IgG4-related disease.
Immunoglobulin G4-related disease (IgG4-RD) is a recently defined emerging clinical entity characterized by tissue infiltration by IgG4-positive plasma cells, tissue fibrosclerosis and elevated serum IgG4 concentration. In this study, patients with IgG4-RD will be investigated, including clinical presentation, laboratory findings and imaging study. All patients will be treated by standard care and follow-uped for at least 6 months.
Study Type
OBSERVATIONAL
Enrollment
1,000
Deptment of Rheumatology, Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
RECRUITINGClinical Response
Clinical Response is measured by IgG4-RD Responder Index, including organ/site score and serum IgG4 level.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.